Paid Advertisement
Secondary stroke prevention doesn’t end at discharge. It calls for long-term risk management and close collaboration between cardiology and neurology.
Join cardiology and stroke experts at AHA Scientific Sessions 2026 for an interactive discussion of residual risk, evolving antithrombotic evidence, and practical approaches to post-stroke care. Together, we’ll explore:
The cardiologist’s role in long-term secondary stroke prevention
What emerging FXIa inhibitor data may mean for clinical practice
Patient selection, safety, and antithrombotic risk–benefit decisions
Practical cardiology–neurology co-management pathways
Bring your questions and be part of the conversation shaping what comes next in secondary stroke prevention.
Click here for more information.
This event is not part of the official Scientific Sessions Conference 2026 as planned by the American Heart Association Committee on Scientific Sessions Programming.